Animal Stem Cell Therapy Market

Animal stem cell therapy is a usage of animal?s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

Animal Stem Cell Therapy Market contains market size and forecasts of Animal Stem Cell Therapy in Global, including the following market information:

Global Animal Stem Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Animal Stem Cell Therapy market was valued at 63 million in 2021 and is projected to reach US$ 80 million by 2028, at a CAGR of 3.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dogs Stem Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Animal Stem Cell Therapy include Medivet Biologics LLC, VETSTEM BIOPHARMA, J-ARM, U.S. Stem Cell, Inc, VetCell Therapeutics, Celavet Inc., Magellan Stem Cells, Kintaro Cells Power and Animal Stem Care, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Animal Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Animal Stem Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Animal Stem Cell Therapy Market Segment Percentages, by Type, 2021 (%)

Dogs Stem Cell Therapy

Horses Stem Cell Therapy

Others Animals

Global Animal Stem Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Animal Stem Cell Therapy Market Segment Percentages, by Application, 2021 (%)

Veterinary Hospitals

Research Organizations

Global Animal Stem Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Animal Stem Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Animal Stem Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Animal Stem Cell Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medivet Biologics LLC

VETSTEM BIOPHARMA

J-ARM

U.S. Stem Cell, Inc

VetCell Therapeutics

Celavet Inc.

Magellan Stem Cells

Kintaro Cells Power

Animal Stem Care

Animal Cell Therapies

Cell Therapy Sciences

Animacel